Published in J Gen Virol on June 01, 1983
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
Yeast tRNA(Asp) recognition by its cognate class II aminoacyl-tRNA synthetase. Nature (1993) 2.57
The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J (2000) 1.86
Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell (1998) 1.63
Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy. J Pathol (1992) 1.41
The impact of protein characterization in structural proteomics. Acta Crystallogr D Biol Crystallogr (2006) 1.32
Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem (2001) 1.15
Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif (2001) 1.14
Preliminary X-ray investigation of 70 S ribosome crystals from Thermus thermophilus. J Mol Biol (1989) 1.07
Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clin Chim Acta (1993) 0.97
Features that distinguish those who die from asthma from community controls with asthma. J Asthma (1998) 0.95
Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. J Mol Biol (2001) 0.92
Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin Immunol Immunopathol (1985) 0.88
Crystallization and preliminary X-ray analysis of Escherichia coli methionyl-tRNA(fMet) formyltransferase. Proteins (1996) 0.86
Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid. Biochem Biophys Res Commun (1997) 0.85
Crystallization of Escherichia coli aspartyl-tRNA synthetase in its free state and in a complex with yeast tRNA(Asp). Acta Crystallogr D Biol Crystallogr (1996) 0.84
Different ligands-different receptor conformations: modeling of the hER alpha LBD in complex with agonists and antagonists. Med Res Rev (2001) 0.83
HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. Regul Pept (1998) 0.83
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res (1999) 0.83
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors. Protein Expr Purif (1999) 0.82
Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor. Protein Expr Purif (1995) 0.80
Improvement in AIDS patients on peptide T. Lancet (1989) 0.76
Local TH1 and TH2 responses to parasitic infection in the intestine: regulation by IFN-gamma and IL-4. Vet Immunol Immunopathol (1996) 0.76
Peptide T and glucose metabolism in AIDS dementia complex. J Nucl Med (1996) 0.76
Digital subtraction indocyanine green angiography of occult choroidal neovascularization. Ophthalmology (1998) 0.75